Healthpeak Properties (DOC) Gets a Buy from RBC Capital
RBC Capital analyst Michael Carroll maintained a Buy rating on Healthpeak Properties on April 14 and set a price target of $20.00. The company’s shares closed yesterday at $16.87.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Carroll covers the Real Estate sector, focusing on stocks such as EPR Properties, Alexandria Equities, and Eastgroup Properties. According to TipRanks, Carroll has an average return of 7.5% and a 61.02% success rate on recommended stocks.
Healthpeak Properties has an analyst consensus of Moderate Buy, with a price target consensus of $18.94, a 12.27% upside from current levels. In a report released on April 14, Bank of America Securities also maintained a Buy rating on the stock with a $20.00 price target.
Based on Healthpeak Properties’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $719.4 million and a net profit of $113.97 million. In comparison, last year the company earned a revenue of $697.99 million and had a net profit of $4.55 million
Read More on DOC:
Disclaimer & DisclosureReport an Issue
- Janus Living initiated with a Buy at BofA
- The Week That Was, The Week Ahead: Macro and Markets, April 12
- Healthpeak Properties price target lowered to $19 from $20 at Baird
- Citi cuts Healthpeak target, opens ‘upside 30-day catalyst watch’
- Healthpeak Properties Expands Credit Facilities to Enhance Liquidity
